Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH)
Norman R Morris1,2,3,4, Menaka Louis5,6, Wendy Strugnell7
1Allied Health Collaborative, The Prince Charles Hospital, Brisbane, Australia. n.morris@griffith.edu.au.
Supervised exercise training may improve exercise capacity and quality of life in pulmonary hypertension (PH) patients. This study evaluates its short and long-term benefits on cardiac function and disease progression.
Area of Science:
- Cardiology
- Pulmonology
- Rehabilitation Medicine
Background:
- Exercise training is crucial for chronic cardiac and respiratory conditions.
- High-quality studies on exercise training in pulmonary hypertension (PH) are limited.
- This study addresses the need for evidence on exercise's role in PH management.
Purpose of the Study:
- To evaluate the short-term and long-term effectiveness of exercise training in PH patients.
- To assess the impact of exercise on exercise capacity, quality of life, cardiac function, and disease progression.
- To determine the safety and benefits of an 8-week outpatient supervised exercise program for PH.
Main Methods:
- A randomized controlled trial involving 50 medically stable PH patients (NYHA class II-III).
- Participants were randomized to supervised exercise training or usual care for 8 weeks.
- Outcomes measured include exercise capacity, cardiac function (including exercise CMRI), quality of life, and clinical worsening over a 2-year follow-up.
Main Results:
- (Study results are pending publication)
Conclusions:
- This study will determine the safety and efficacy of outpatient supervised exercise training in PH patients.
- It will provide novel insights into exercise's impact on right heart function using exercise CMRI.
- Findings will inform clinical practice guidelines and enhance understanding of exercise benefits in PH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Hypertension III: Clinical Manifestations and Diagnostic Studies

